Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Prenate Pixie** is a prescription prenatal softgel vitamin supplement designed for easy swallowing, particularly during preconception, pregnancy, and postpartum periods. It contains 11 key nutrients including **folic acid** (traditional and **levomefolate calcium** for better absorption in women with MTHFR mutations), **DHA** from fish oil for fetal brain development, highly absorbable **ferrous asparto glycinate** (Sumalate iron), **vitamin D3**, **vitamin B6**, **biotin**, **vitamin C**, **vitamin E**, **iodine**, **vitamin B12**, and **blueberry extract** to reduce aftertaste and burp-back while providing antioxidants. The small size (less than one-third a penny) and once-daily dosing promote compliance; it is gluten-free, lactose-free, sugar-free, and supports neural tube closure, gestational length, cognitive development, and maternal nutrition.[1][3][4][5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Prenate Pixie.